Teclistamab is a T-cell–redirecting bispecific antibody that targets both CD3 expressed on the surface of T cells and B-cell maturation antigen expressed on the surface of myeloma cells. In the phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback